The Oxford University Covid-19 vaccine undergoing Phase III clinical trials with British pharma giant AstraZeneca is doing everything expected which means good news in the fight against the deadly virus, an independent analysis said on Thursday.
A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.
The experts say that the novel analysis provides even greater clarity and detail about how the vaccine successfully provokes a strong immune response.
"This is an important study as we are able to confirm that the genetic